Inditrade Capital’s Group Chairman, Sudip Bandyopadhyay, favors life insurance, particularly LIC, citing its strong quarterly results and long-term potential. While cautious about health insurance due to market uncertainties, he highlights domestic-focused pharma like Mankind Pharma and hospital chains like Apollo Hospitals as promising investments, while advising caution on diagnostic companies due to intense competition.
Adani’s Cemindia is said to near up to $524 million share sale
Adani Group-backed Cemindia Projects, formerly known as ITD Cementation India, is preparing to launch a qualified institutional placement (QIP) to raise up to Rs 5,000
August 26, 2026